Back
Givaudan SA Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
82
GVDNY
Givaudan SA
Last Price:
$99.17
Seasonality Move:
4.12%
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$36.99
Seasonality Move:
14.03%
Buy
82
Givaudan SA (GVDNY)
is a Buy
Is Givaudan SA a Buy, Sell or Hold?
-
The current Givaudan SA [GVDNY] share price is $99.17. The Score for GVDNY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $36.99. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GVDNY Stock Price Chart
What is Givaudan SA's stock price today?
-
The Givaudan SA share price today is $99.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVDNY is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $36.99The current trend is moderately bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
GVDNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.84 | Buy |
Relative Strength Index (14 RSI): | 64.36 | Buy |
Chaikin Money Flow: | -8606 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (93.13 - 98.05) | Buy |
Bollinger Bands (100): | (85.52 - 93.86) | Buy |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.44 | Buy |
Relative Strength Index (14 RSI): | 48.65 | Sell |
Chaikin Money Flow: | -1828559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.94 - 38.92) | Sell |
Bollinger Bands (100): | (36.19 - 44.05) | Sell |
GVDNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.97 | Buy |
20-day SMA: | 96.45 | Buy |
50-day SMA: | 92.04 | Buy |
200-day SMA: | 93.44 | Buy |
8-day EMA: | 97.82 | Buy |
20-day EMA: | 96.13 | Buy |
50-day EMA: | 93.3 | Buy |
200-day EMA: | 91.18 | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.55 | Sell |
20-day SMA: | 37.23 | Sell |
50-day SMA: | 37.71 | Sell |
200-day SMA: | 44.05 | Sell |
8-day EMA: | 37.57 | Sell |
20-day EMA: | 36.79 | Buy |
50-day EMA: | 30.73 | Buy |
200-day EMA: | 13.2 | Buy |
Givaudan SA Earnings Growth & GVDNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.31 per share, and an increase next year of $1.03 per share.
Givaudan SA Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |